期刊论文详细信息
Health and Quality of Life Outcomes
Measurement of diabetes-related emotional distress using the Problem Areas in Diabetes scale: psychometric evaluations show that the short form is better than the full form
Moon-Suk Nam2  Yong Seong Kim2  Kwan-Woo Lee3  Young Whee Lee1  Eun-Hyun Lee4 
[1] Department of Nursing, Inha University, Incheon, Republic of Korea;Division of Endocrinology & Metabolism, School of Medicine, Inha University, Incheon, Republic of Korea;Department of Endocrinology and Metabolism, School of Medicine, Ajou University, Suwon, Republic of Korea;Graduate School of Public Health, Ajou University, 164 Worldcup-ro, Yeongtong-gu, Suwon-si 443-380, Gyeonggi-do, Republic of Korea
关键词: Translation;    Psychometric properties;    Distress;    Emotion;    Diabetes;   
Others  :  1164505
DOI  :  10.1186/s12955-014-0142-z
 received in 2014-08-08, accepted in 2014-09-08,  发布年份 2014
PDF
【 摘 要 】

Background

The Problem Areas in Diabetes (PAID) scale is widely used for measuring diabetes-related emotional distress. There has been debate over the last 2 decades about the underlying factorial-construct validity of the PAID, with one- to four-factor structures being reported. A short form of the PAID, which comprises five items (PAID-5), was recently developed using Western patients with type 2 diabetes. This study measured the psychometric properties of the full and short forms of the PAID in Korean patients with type 2 diabetes, with the aim of determining which form is preferable.

Methods

The PAID and PAID-5 were translated into Korean (K-PAID and K-PAID-5, respectively) using a forward-and-backward translation technique. The study participants were recruited from university hospitals. The factorial-construct, convergent, and known-groups validity, and internal-consistency and test¿retest reliability of both the K-PAID and K-PAID-5 were evaluated.

Results

For the K-PAID, confirmatory factor analysis revealed a marginal fit to the one-, two-, three-, and four-factor models. The three- and four-factor models of the K-PAID partially satisfied the internal-consistency and test¿retest reliability, and convergent and known-groups validity. For the K-PAID-5, confirmatory factor analysis demonstrated an excellent fit to the one-factor model, with a Cronbach¿s alpha of 0.87 and an intraclass correlation coefficient of 0.89. The K-PAID-5 satisfied the convergent validity, as evaluated using the Center for Epidemiologic Studies Depression Scale and hemoglobin A1c. Known-groups validity by gender was also satisfied.

Conclusions

The K-PAID-5 demonstrated excellent psychometric properties as a one-factor scale. The brevity of the K-PAID-5 represents a major advantage in a practical context in that it may impose a minimum burden upon patients with diabetes.

【 授权许可】

   
2014 Lee et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150415091349711.pdf 258KB PDF download
【 参考文献 】
  • [1][http://www.idf.org/diabetesatlas/download-book] webcite International Diabetes Federation: Diabetes atlas. 6th edition. .
  • [2]Pouwer F: Should we screen for emotional distress in type 2 diabetes mellitus? Nat Rev Endocrinol 2009, 5:665-671.
  • [3]Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE: Assessment of diabetes-related distress. Diabetes Care 1995, 18:754-760.
  • [4]Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U: Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010, 33:23-28.
  • [5]Wang R-H, Wu L-C, Hsu H-Y: A path model of health-related quality of life in type 2 diabetic patients: a cross-sectional study in Taiwan. J Adv Nurs 2011, 67:2658-2667.
  • [6]Standards of medical care in diabetes ¿ 2014 Diabetes Care 2014, 37:S14-S80.
  • [7][http:/ / fda.gov/ downloads/ Drugs/ GuidanceComplianceRegulatoryInforma tion/ UCM193282.pdf] webcite United States Food and Drug Administration: Guidance for industry. patient-reported outcome measures: use in medical product development to support labeling claims..
  • [8]Welch GW, Jacobson AM, Polonsky WH: The Problem Areas in Diabetes scale: an evaluation of its clinical utility. Diabetes Care 1997, 20:760-766.
  • [9]Snoek FJ, Pouwer F, Welch GW, Polonsky WH: Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care 2000, 23:1305-1309.
  • [10]Amsberg S, Wredling R, Lins PE, Adamson U, Johansson UB: The psychometric properties of the Swedish version of the Problem Areas in Diabetes scale (Swe-PAID-20): scale development. Int J Nurs Stud 2008, 45:1319-1328.
  • [11]Arzaghi SM, Mahjouri MY, Heshmat R, Khashayar P, Larijani B: Psychometric properties of the Iranian version of the Problem Areas in Diabetes scale (IR-PAID-20). Iran J Diabetes Metab Disord 2011, 10:1-7.
  • [12]Papathanasiou A, Koutsovasilis A, Shea S, Philalithis A, Papavasiliou S, Melidonis A, Lionis C: The Problem Areas in Diabetes (PAID) scale: psychometric evaluation survey in a Greek sample with type 2 diabetes. J Psychiatr Ment Health Nurs 2014, 21:345-353.
  • [13]Miller ST, Elasy TA: Psychosomatic evaluation of the Problem Areas in Diabetes (PAID) survey in Southern, rural African American women with Type 2 diabetes. BMC Public Health 2008, 8:70. BioMed Central Full Text
  • [14]Sigurdardottir AK, Benediktsson R: Reliability and validity of the Icelandic version of the Problem Area in Diabetes (PAID) Scale. Int J Nurs Stud 2008, 45:526-533.
  • [15]Veld EM HI¿t, Makine C, Nouwen A, Karsidag C, Kadioglu P, Karsidag K, Pouwer F: Validation of the Turkish version of the problem areas in diabetes scale. Cardiovasc Psychiatr Neurol 2011, 2011:315068.
  • [16]Huang MF, Courtney M, Edward H, McDowell J: Validation of the Chinese version of the Problem Areas in Diabetes (PAID-C) scale. Diabetes Care 2010, 33:38-40.
  • [17]Welch G, Schwartz CE, Santiago-Kelly P, Garb J, Shayne R, Bode R: Disease-related emotional distress of Hispanic and non-Hispanic type 2 diabetes patients. Ethn Dis 2007, 17:541-547.
  • [18]Hsu H-C, Chang Y-H, Lee P-J, Chen S-Y, Hsieh C-H, Lee Y-J, Wang R-H: Developing and psychometric testing of a short-form problem areas in diabetes scale in Chinese patients. J Nurs Res 2013, 21:212-218.
  • [19]Graue M, Haugstvedt A, Wentzel-Larsen T, Iversen MM, Karlsen B, Rokne B: Diabetes-related emotional distress in adults: reliability and validity of the Norwegian versions of the Problem Areas in Diabetes scale (PAID) and the Diabetes Distress Scale (DDS). Int J Nurs Stud 2012, 49:174-182.
  • [20]Floyd FJ, Widaman KF: Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess 1995, 7:286-299.
  • [21]McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, Kokoszka A, Atthews D, Pibernik-Okanovi? M, Rodríguez-Saldaña J, de Wit M, Snoek FJ: Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia 2010, 53:66-69.
  • [22]Welch G, Weinger K, Anderson B, Polonsky WH: Responsiveness of the Problem Areas in Diabetes (PAID) questionnaire. Diabet Med 2003, 20:69-72.
  • [23]Brislin RW: Back-translation for cross-cultural research. J Cross Cult Psychol 1970, 1:185-216.
  • [24]Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
  • [25]Cho MJ, Kim KH: Use of Center for Epidemiologic Studies Depression (CES-D) Scale in Korea. J Nerv Ment Dis 1998, 186:304-310.
  • [26]Reddy J, Wilhelm K, Campbell L: Putting PAID to diabetes-related distress: the potential utility of the problem areas in diabetes (PAID) scale in patients with diabetes. Psychosomatics 2013, 54:44-51.
  • [27]de Vet HCW, Terwee CB, Mokkink LB, Knol DL: Measurement in medicine: a practical guide. Cambridge University Press, New York; 2011.
  • [28]Hu LT, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999, 6:1-55.
  • [29]Kline RB: Principles and practice of structural equation modeling. Guilford Press, New York; 2005.
  • [30]MacCallum RC, Browne MW, Sugawara HM: Power analysis and determination of sample size for covariance structure modeling. Psychol Methods 1996, 1:130-149.
  • [31]Tabachnick BG, Fidell LS: Using multivariate statistics. Pearson Education, Upper Saddle River; 2012.
  • [32]Byrne BM: Structural equation modeling with AMOS: Basic concepts, applications and programming. Routledge, New York; 2010.
  • [33]Mitchell RJ: Path analysis: pollination. In Design and analysis of ecological experiments. Edited by Schneider SM, Gurevith J. Chapman and Hall, New York; 1998:221-231.
  • [34]Cabassa LJ, Lagomasino IT, Dwight-Johnson M, Hansen MC, Xie B: Measuring Latinos¿ perceptions of depression: a confirmatory factor analysis of the illness perception questionnaire. Cultur Divers Ethnic Minor Psychol 2008, 14:377-384.
  • [35]Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA: Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care 2005, 28:626-631.
  • [36]Pett MA, Lackey NR, Sullivan JJ: Making sense of factor analysis. Sage, Thousand Oaks; 2003.
  • [37]Gross CC, Scain SF, Scheffel R, Gross JL, Hutz CS: Brazilian version of the Problem Areas in Diabetes Scale (B-PAID): validation and identification of individuals at high risk for emotional distress. Diabetes Res Clin Pract 2007, 76:455-459.
  • [38]Cook JD, Hepworth SJ, Warr PB: The experience of work. Academic Press, San Diego; 1981.
  • [39]van Bastelaar KM, Power F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AT, Heine RJ, Snoek FJ: Diabetes-specific emotional distress mediates the association between depressive symptoms and glycemic control in Type 1 and type 2 diabetes. Diabet Med 2010, 27:798-803.
  • [40]Eigenmann CA, Colagiuri R, Skinnert TC, Trevena L: Are current psychometric tools suitable for measuring outcomes of diabetes education? Diabet Med 2009, 26:425-436.
  • [41]Keers JC, Groen H, Sluiter WJ, Bouma J, Links TP: Cost and benefits of a multidisciplinary intensive diabetes education programme. J Eval Clin Pract 2005, 11:293-303.
  • [42]Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC: Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007, 60:34-42.
  文献评价指标  
  下载次数:14次 浏览次数:70次